- Recommendation ID
- DG19/2
- Question
What proportion of people with melanoma who are referred into secondary care under the 2 week wait rule, have equivocal moles that are excised and have equivocal moles that are monitored?
- Any explanatory notes
(if applicable) None
Source guidance details
- Comes from guidance
- VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions
- Number
- DG19
- Date issued
- November 2015
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 16/12/2015 |